Journal Description
Endocrines
Endocrines
is an international, peer-reviewed, open access journal on endocrinology published quarterly online by MDPI.
- Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
- High Visibility: indexed within Scopus, CAPlus / SciFinder, and other databases.
- Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 26.5 days after submission; acceptance to publication is undertaken in 4.8 days (median values for papers published in this journal in the second half of 2024).
- Recognition of Reviewers: APC discount vouchers, optional signed peer review, and reviewer names published annually in the journal.
Latest Articles
Cholesterol and Bone Resorption: Yet Another Link Between the Bone and Cardiovascular Systems
Endocrines 2025, 6(2), 19; https://doi.org/10.3390/endocrines6020019 - 16 Apr 2025
Abstract
This review examines the relationship between cholesterol and bone resorption. It seeks to elucidate the dependence of bone turnover on cholesterol metabolism by highlighting the common inhibitory effect of both statins and nitrogen-containing bisphosphonates on cholesterol biosynthesis and bone resorption as well as
[...] Read more.
This review examines the relationship between cholesterol and bone resorption. It seeks to elucidate the dependence of bone turnover on cholesterol metabolism by highlighting the common inhibitory effect of both statins and nitrogen-containing bisphosphonates on cholesterol biosynthesis and bone resorption as well as on bone density. Moreover, this paper also discusses the epidemiologic studies of the effects of nitrogen-containing bisphosphonates on all-cause and cardiovascular mortality using the latest publications to reinforce the relationship between bone resorption and cardiovascular disease. This review will also discuss the role of lipoproteins in supplying cholesterol to both osteoclasts and osteoblasts and the effects of doing so on both of these bone cells and their precursors. As inflammation is a major factor in both bone resorption and cardiovascular calcification, this article will also discuss the role of cholesterol in triggering inflammatory responses. Finally, this paper will raise questions unanswered to date that bear on the relationship between lipid metabolism, bone resorption, and cardiovascular disease.
Full article
(This article belongs to the Section Parathyroid Disorders, Mineral Metabolism and Bone Functions)
►
Show Figures
Open AccessCommunication
Endocrinology of Primary Ovarian Insufficiency: Diagnostic and Therapeutic Clues
by
Jan Tesarik
Endocrines 2025, 6(2), 18; https://doi.org/10.3390/endocrines6020018 - 8 Apr 2025
Abstract
Background: This paper briefly reviews the most important endocrine features of primary ovarian insufficiency (POI) and shows their relevance for the diagnosis and treatment of this condition. Introduction: Endocrine disturbances in POI cause problems for both the fertility and general health status of
[...] Read more.
Background: This paper briefly reviews the most important endocrine features of primary ovarian insufficiency (POI) and shows their relevance for the diagnosis and treatment of this condition. Introduction: Endocrine disturbances in POI cause problems for both the fertility and general health status of the affected women. Both subfertility and infertility result from the depletion of growing ovarian follicles which, in its turn, is the causative factor of hypoestrogenism; this is responsible for most of the general health problems affecting women. Method: Search of literature. Results and conclusion: A combination of high-serum follicle-stimulating hormone (FSH) and low 17β-estradiol (E2) concentrations is a key feature characterizing POI and is the decisive element for POI diagnosis. However, an in-depth search for possible genetic and non-genetic causes is important for adequate counseling regarding prevention and early intervention. The treatment of general health problems, based on correcting hypoestrogenism through hormone replacement therapy (HRT), is relatively easy. On the other hand, resolving infertility is a much more difficult task, and oocyte donation is the only really efficient instrument. Fertility preservation is a suitable alternative in patients with early POI diagnosis, in whom some viable follicles are still present in the ovaries. In patients who refuse oocyte donation, intraovarian injection of autologous platelet-rich plasma and in vitro activation of dormant follicles may be considered. Other innovative treatments, such as stem cell therapies or nuclear transfer, are currently under investigation.
Full article
(This article belongs to the Section Female Reproductive System and Pregnancy Endocrinology)
Open AccessArticle
Comprehensive Insights into Anxiety, Depression, and Glycemic Control in Adolescents with Type 1 Diabetes and Their Parents: A First Look in Latvia and Implications for Multidisciplinary Care
by
Evija Silina, Maksims Zolovs, Iveta Dzivite-Krisane, Inta Zile and Maris Taube
Endocrines 2025, 6(2), 17; https://doi.org/10.3390/endocrines6020017 - 7 Apr 2025
Abstract
Background/Objectives: Chronic somatic diseases are significant risk factors for the development of mental disorders. Type 1 diabetes mellitus (T1D) is the most common chronic endocrine pathology in children. Treatment requires nutrition management, physical activity, lifelong insulin therapy, and proper self-monitoring of blood glucose.
[...] Read more.
Background/Objectives: Chronic somatic diseases are significant risk factors for the development of mental disorders. Type 1 diabetes mellitus (T1D) is the most common chronic endocrine pathology in children. Treatment requires nutrition management, physical activity, lifelong insulin therapy, and proper self-monitoring of blood glucose. It is complicated and therefore may result in a variety of psychosocial problems for children, adolescents, and their families. Considering the rapidly growing incidence of type 1 diabetes in the pediatric population of Latvia, it is important to detect and prevent the risks of anxiety and depression in families with children suffering from type 1 diabetes. Methods: This was a quantitative interdisciplinary cross-sectional study to determine the prevalence of anxiety and depression in adolescents with T1D and their parents. Two tools were used to detect the presence of symptoms of anxiety and depression: the Generalized Anxiety Disorder Scale-7 (GAD-7) and the Patient Health Questionnaire 9 (PHQ-9) scale. Results: A total of 812 respondents were eligible for screening. Anxiety and depression symptoms were seen significantly more frequently in the study group than in the control group. The study found negative effects of anxiety and depression on the compensation of diabetes. Conclusions: Adolescents with type 1 diabetes and their parents are more predisposed to anxiety and depression symptoms than somatic healthy children and their parents, thus worsening disease control and prognosis.
Full article
(This article belongs to the Special Issue Recent Advances in Type 1 Diabetes)
►▼
Show Figures

Figure 1
Open AccessReview
Effect of GnRH Analog Therapy on Adult Height in Girls with Idiopathic Central Precocious Puberty
by
Reiko Saito and Yukihiro Hasegawa
Endocrines 2025, 6(2), 16; https://doi.org/10.3390/endocrines6020016 - 2 Apr 2025
Abstract
Precocious puberty (PP) is characterized by the early onset of secondary sexual characteristics and accelerated growth, which often result in compromised adult height (AH). Central precocious puberty (CPP), a subset of PP, is treated with gonadotropin-releasing hormone analogs (GnRHa) to suppress premature hormonal
[...] Read more.
Precocious puberty (PP) is characterized by the early onset of secondary sexual characteristics and accelerated growth, which often result in compromised adult height (AH). Central precocious puberty (CPP), a subset of PP, is treated with gonadotropin-releasing hormone analogs (GnRHa) to suppress premature hormonal activation and delay epiphyseal closure, thereby preserving height potential. The present review examined the effects of GnRHa on AH outcomes in girls with idiopathic CPP. Although AH is greater with GnRHa therapy than without it, the treatment does not consistently restore the patient’s genetic potential. The benefits of the treatment are most evident in girls in whom idiopathic CPP is diagnosed before 6 years of age and they achieve a height gain of 4.5–14.1 cm, which is unattainable without treatment. However, the treatment of older children (ages 6–8) shows conflicting results, with the AH outcome varying among previous reports. In particular, slowly progressive CPP is known to have a favorable height prognosis even without treatment. Another factor influencing the AH prognosis is the timing of GnRHa discontinuation; the best time to discontinue GnRHa therapy for the best AH outcome is reportedly the bone age of approximately 12 years. In conclusion, although GnRHa therapy significantly improves the AH, especially in early-onset CPP, its effectiveness is uncertain in borderline or late-onset cases. Further research is required to formulate more precise criteria for patient selection and treatment discontinuation to optimize height outcome in girls with idiopathic CPP.
Full article
(This article belongs to the Section Pediatric Endocrinology and Growth Disorders)
Open AccessArticle
Ultrasound Assessment and Sexual Dimorphism of Thyroid Nodules: Bringing Gender Medicine to Clinical Practice
by
Marina Valenzano, Ruth Rossetto Giaccherino, Loredana Pagano, Sara Garberoglio and Roberto Garberoglio
Endocrines 2025, 6(2), 15; https://doi.org/10.3390/endocrines6020015 - 1 Apr 2025
Abstract
Background/Objectives: Understanding sex-based differences in both the pathophysiology and clinical presentation of diseases is necessary to improve health care towards precision medicine. The endocrine system is deeply involved in human health, and endocrine diseases may be influenced by steroidal hormone exposure. Thyroid
[...] Read more.
Background/Objectives: Understanding sex-based differences in both the pathophysiology and clinical presentation of diseases is necessary to improve health care towards precision medicine. The endocrine system is deeply involved in human health, and endocrine diseases may be influenced by steroidal hormone exposure. Thyroid nodular disease and differentiated thyroid cancer, in particular, show a high prevalence in the female sex; however, little is known about sex-related differences in risk factors and clinical presentation. This study aims to assess whether morphological differences, which can be detected by ultrasound examination, can be related to sex in order to refine diagnostic approaches and oncological risk classification. Methods: A retrospective observational study on 1355 ultrasound images of thyroid nodules obtained from 2017 to 2020 at a single university center was conducted. The images were reviewed by a single observer blinded to the patient’s sex and the cytological nature of the nodules. The qualitative description, size, anatomical location and oncological risk classification were assessed. Results: A taller-than-wide shape (anteroposterior/craniocaudal axis ratio > 1) was found to be more frequent in men than in women (6.7% vs. 3.6%, p = 0.027); the nodular volume was significantly larger in males (p << 0.01) than in females. Significant tropism for the upper lobe and isthmus was described in women (26% vs. 16.5%, p = 0.011) and for medium–lower thyroid lobes in men (83.5% vs. 73.8%, p = 0.011). Background thyroiditis was more common in women, while the number of cytological diagnoses of malignant or likely malignant nodules was higher than expected in men (9% vs. 6%, p = 0.01). Conclusions: Thyroid nodules show different distributions, in terms of a larger volume, more frequent taller-than-wide shape and lobular caudal location, in men vs. women. These results should be confirmed by further investigations, and the underlying mechanism should be clarified. However, our explorative research is of interest due to its novelty and possible future clinical implications.
Full article
(This article belongs to the Section Thyroid Endocrinology)
►▼
Show Figures

Figure 1
Open AccessArticle
Effects of the Menstrual Cycle Phase on Cortisol Responses to Maximum Exercise in Women With and Without Premenstrual Syndrome
by
Raul Cosme Ramos Prado, Tamires Nunes Oliveira, Bryan Saunders, Roberta Foster, Zsuzsanna Ilona Katalin de Jármy Di Bella, Marcus W. Kilpatrick, Ricardo Yukio Asano, Anthony C. Hackney and Monica Yuri Takito
Endocrines 2025, 6(1), 14; https://doi.org/10.3390/endocrines6010014 - 20 Mar 2025
Abstract
Objectives: This study investigated the effects of the menstrual cycle phases on cortisol levels before and after a maximal incremental exercise test in women with and without premenstrual syndrome (PMS). Methods: Nineteen healthy, active and eumenorrheic women completed five maximal incremental
[...] Read more.
Objectives: This study investigated the effects of the menstrual cycle phases on cortisol levels before and after a maximal incremental exercise test in women with and without premenstrual syndrome (PMS). Methods: Nineteen healthy, active and eumenorrheic women completed five maximal incremental exercise tests; three of those were performed at specific phases of the menstrual cycle (i.e., menses, follicular, and luteal). The participants were allocated into two groups according to the presence of PMS (n = 11) or absence of PMS (NO-PMS, n = 8). Samples of blood were collected before and after each experimental test. A three-way ANOVA was conducted to compare the differences between menstrual cycle phases (i.e., menses, follicular, and luteal), time (before and after) and groups (PMS and NO-PMS). Results: The results demonstrated an alteration of cortisol across the menstrual cycle, with cortisol levels significantly (p < 0.05) higher during the follicular phase (mean = 11.0 µg/dL, CI95% = 9.1, 12.9) compared to the luteal phase (mean = 8.6 µg/dL, CI95% = 7.2, 10.4) in the PMS and NO-PMS groups. There was no difference (p > 0.05) in cortisol levels for groups or time. Conclusions: This study observed significant cortisol fluctuations across the menstrual cycle phases in women with and without PMS. Future studies should consider alternative maximal incremental test protocols and incorporate a more comprehensive hormonal profile to provide a deeper physiological understanding of this population.
Full article
(This article belongs to the Section Exercise Endocrinology)
►▼
Show Figures

Figure 1
Open AccessReview
Link Between Umbilical Cord Blood Adipokines and Early Childhood Health
by
Ava M. Boyle, Olivia J. Holland and Deanne H. Hryciw
Endocrines 2025, 6(1), 13; https://doi.org/10.3390/endocrines6010013 - 11 Mar 2025
Abstract
Introduction: Early-life neurological and inflammatory disorders significantly affect long-term cognitive, social, and emotional development. The ‘Developmental Origins of Health and Disease’ hypothesis states that an adverse intrauterine environment may predispose offspring to chronic health conditions due to altered growth and development. Factors measured
[...] Read more.
Introduction: Early-life neurological and inflammatory disorders significantly affect long-term cognitive, social, and emotional development. The ‘Developmental Origins of Health and Disease’ hypothesis states that an adverse intrauterine environment may predispose offspring to chronic health conditions due to altered growth and development. Factors measured in umbilical cord blood can provide information about the status of the in utero environment during development. Evidence indicates that umbilical cord blood adipokines, namely leptin and adiponectin, may influence fetal programming and could be useful in predicting offspring health outcomes. Leptin and adiponectin are crucial in energy homeostasis, immune response, and placental function, and some studies suggest that altered concentrations may increase the risk of developing inflammatory and neurological disorders in later life. Further, limited studies have demonstrated sex-specific differences in adipokine concentrations and disease risk. Conclusions: Understanding the role of umbilical cord blood adipokines in fetal programming could offer new insights into early risk prediction and intervention strategies, promoting better health outcomes for children at risk of neurological and inflammatory diseases due to an adverse maternal environment during pregnancy.
Full article
(This article belongs to the Section Female Reproductive System and Pregnancy Endocrinology)
►▼
Show Figures

Figure 1
Open AccessArticle
Comparative Study of 0.5 mg Dienogest Tablets (1 mg/Day) and Continuous Low-Dose Estrogen/Progestin for Dysmenorrhea: A Retrospective Analysis—Influence of Bleeding-Related Factors Such as Endometrial Polyps, Uterine Fibroids, and Adenomyosis
by
Haruko Yokosuka
Endocrines 2025, 6(1), 12; https://doi.org/10.3390/endocrines6010012 - 6 Mar 2025
Abstract
Background/Objectives: Dienogest 0.5 mg tablets (DNG0.5) taken twice daily (1 mg/day) are more effective than cyclic low-dose estrogen/progestin/combined oral contraceptive (LEP/COC) in ameliorating dysmenorrhea pain and are recommended for dysmenorrhea treatment in Japan. However, their efficacy has not been directly compared with continuous
[...] Read more.
Background/Objectives: Dienogest 0.5 mg tablets (DNG0.5) taken twice daily (1 mg/day) are more effective than cyclic low-dose estrogen/progestin/combined oral contraceptive (LEP/COC) in ameliorating dysmenorrhea pain and are recommended for dysmenorrhea treatment in Japan. However, their efficacy has not been directly compared with continuous LEP/COC regimens. Here, we evaluated the effectiveness of DNG0.5 compared to Yazflex® (YZF), a continuous LEP, in treating dysmenorrhea. Methods: The efficacy of DNG0.5 in treating dysmenorrhea was compared retrospectively with that of Yazflex, the longest continuously administered LEP/COC available in Japan. Results: The improvement rates of dysmenorrhea scores at 3 and 6 months post-treatment were 59.1% and 66.4% in the LEP group (n = 113) and 88.1% and 96.4% in the DNG0.5 group (n = 125), respectively. The complete resolution rate of dysmenorrhea at 6 months was 88.0% in the DNG0.5 group and 23.9% in the LEP group. These findings indicate that DNG0.5 was significantly more effective than LEP (p < 0.01). DNG0.5 exerted an early pain-suppressing effect, which continued to increase thereafter. Furthermore, the presence of endometrial polyps, uterine fibroids, or adenomyosis, which are risk factors for irregular genital bleeding, was examined. Among these, endometrial polyps were particularly more likely to cause bleeding and potentially reduce the effect of DNG0.5; however, even with these three risk factors, DNG0.5 was more effective than LEP in reducing pain. Conclusions: Dienogest was more effective than LEP in managing dysmenorrhea, even at a dosage of 0.5 mg twice daily. However, factors affecting irregular vaginal bleeding should be considered when prescribing DNG0.5.
Full article
(This article belongs to the Section Female Reproductive System and Pregnancy Endocrinology)
Open AccessReview
The Potential of Zebrafish Larvae and Water Vortex Protocols in Stress Biology
by
Rodrigo J. De Marco
Endocrines 2025, 6(1), 11; https://doi.org/10.3390/endocrines6010011 - 4 Mar 2025
Abstract
Stress responses enable vertebrates to adapt to environmental challenges while maintaining homeostasis. Zebrafish larvae are a valuable model for studying stress regulation due to their genetic accessibility and rapid development. This review examines the integration of zebrafish larvae with water vortex protocols to
[...] Read more.
Stress responses enable vertebrates to adapt to environmental challenges while maintaining homeostasis. Zebrafish larvae are a valuable model for studying stress regulation due to their genetic accessibility and rapid development. This review examines the integration of zebrafish larvae with water vortex protocols to investigate hypothalamic–pituitary–interrenal (HPI) axis functionality during early development, advancing stress research while adhering to the 3Rs principle. Key publications are reviewed to discuss the potential of water vortices in zebrafish larvae for studying stress responses. These purely physical stressors exploit the innate positive rheotropism of developing zebrafish, offering precise control over timing and strength while avoiding confounding factors associated with chemical or biological interventions. The approach enables reproducible assessments of stress responses. The reviewed publications show advances in understanding cortisol response dynamics, glucocorticoid feedback, and early-life stress-induced changes in HPI axis function. Key findings include detailed cortisol patterns after acute stress, rapid glucocorticoid receptor-mediated feedback regulating cortisol levels, developmental shifts in HPI axis sensitivity, and reduced cortisol reactivity following early-life challenge (ELC). Vortex-driven ELC affects cortisol regulation, neuropeptide expression in the nucleus preopticus, and stress-related gene transcription. Combining zebrafish larvae and vortex protocols provides a robust and innovative platform for investigating stress biology. This approach leverages active, demanding behaviour to study stress mechanisms under controlled conditions, yielding insights with broad applications across vertebrate models while supporting the 3Rs principle. Future studies can build on these findings to address unresolved questions in stress regulation and enhance our understanding of adaptive physiological mechanisms.
Full article
Open AccessReview
Nutrition and Physical Activity in Musculoskeletal Health
by
Ligia J. Dominguez, Nicola Veronese, Lee Smith, Francesco Saverio Ragusa, Giovanna Di Bella, Giuseppe Battaglia, Antonino Bianco and Mario Barbagallo
Endocrines 2025, 6(1), 10; https://doi.org/10.3390/endocrines6010010 - 4 Mar 2025
Abstract
A balanced diet and regular physical activity are essential for maintaining musculoskeletal health. Key nutrients such as calcium, vitamin D, and protein are especially important for preventing falls and fractures. While the benefits of these nutrients are well-established, other dietary components have not
[...] Read more.
A balanced diet and regular physical activity are essential for maintaining musculoskeletal health. Key nutrients such as calcium, vitamin D, and protein are especially important for preventing falls and fractures. While the benefits of these nutrients are well-established, other dietary components have not been studied as extensively. For instance, vegetables, which are rich in nutrients vital for muscle and bone health, play a crucial role in preventing falls and fractures. Over recent decades, a great emphasis has been given to the combinations of nutrients and foods in dietary patterns that may have synergistic or antagonistic effects. Despite the challenges in researching the impact of nutrition and physical activity on musculoskeletal health due to the extensive heterogeneity of the results, healthcare professionals should continue to promote healthy eating and regular physical activity, and these principles should be emphasized in public health initiatives. Ultimately, a sufficient and balanced diet, abundant in plant-based foods and low in processed or discretionary foods, along with consistent physical activity, remains the most effective strategy for the prevention of musculoskeletal issues. This article aims to review the updated literature of recent years on the links between nutrition and physical activity with bone and skeletal muscle health.
Full article
(This article belongs to the Special Issue Feature Papers in Endocrines: 2024)
►▼
Show Figures

Figure 1
Open AccessArticle
Induction of Mandibular Cortical Bone Defects to Study Bone Regeneration
by
Elizabeth K. Vu, Grant Kim, Mitchell J. Shimak, Ismael Y. Karkache, Jinsha Koroth, Emily Chavez, Samuel Mitchell, Rachel B. Clark, Kim C. Mansky and Elizabeth W. Bradley
Endocrines 2025, 6(1), 9; https://doi.org/10.3390/endocrines6010009 - 14 Feb 2025
Abstract
►▼
Show Figures
Background/Objectives: In contrast to endochondral bone healing, the process of intramembranous bone regeneration is poorly understood. This limits our ability to repair and regenerate the craniofacial skeleton to either correct deformity or optimally heal tissues following injury. While there are several preclinical models
[...] Read more.
Background/Objectives: In contrast to endochondral bone healing, the process of intramembranous bone regeneration is poorly understood. This limits our ability to repair and regenerate the craniofacial skeleton to either correct deformity or optimally heal tissues following injury. While there are several preclinical models of intramembranous regeneration within the craniofacial skeleton, some are not load bearing and others are technically challenging. The goal of this pilot study is therefore to describe a simple method for induction of cortical defects within the mandible that does not involve compounding injury to the surrounding tissues. Methods: Single cortex defects were generated in the mandible body of 8-week-old male and female mice. The extent of bone regeneration within the defect was characterized at days 0, 3, 14, and 28 following defect generation via micro-computed tomography and histology. Conclusions: Observed healing was predictable and reproducible and resulted in intramembranous bone formation. This model will help aid the understanding of intramembranous bone healing in load bearing bones (e.g., mandible) within the craniofacial skeleton
Full article

Figure 1
Open AccessArticle
Impact of Parathormone (PTH) Levels on the Presence of Cardiovascular Disease in Patients with Primary Aldosteronism and Essential Hypertension
by
Álvaro Fernández-Sánchez, Diego Meneses, Emma Raquel Alegre Bellasai, Jersy Cárdenas-Salas, Amalia Paniagua, Clotilde Vázquez and Jorge Gabriel Ruiz-Sánchez
Endocrines 2025, 6(1), 8; https://doi.org/10.3390/endocrines6010008 - 13 Feb 2025
Abstract
Background/Objectives: Primary aldosteronism (PA) is associated with a higher cardiovascular disease (CVD) risk than essential hypertension (EH) and is mainly driven by the excess of aldosterone production. Studies suggest a relationship between aldosterone and parathormone (PTH) homeostasis. Excessive PTH levels seem to also
[...] Read more.
Background/Objectives: Primary aldosteronism (PA) is associated with a higher cardiovascular disease (CVD) risk than essential hypertension (EH) and is mainly driven by the excess of aldosterone production. Studies suggest a relationship between aldosterone and parathormone (PTH) homeostasis. Excessive PTH levels seem to also be associated with CVD. The impact of PTH levels on CVD in PA patients has not been totally elucidated. We evaluated the associations of PTH levels and hyperparathyroidism with CVD in patients with PA and EH. Methods: A cross-sectional study of a group of 67 patients was carried out, with 35 patients with PA and a control group of 32 patients with EH. We looked at the presence of CVD and data on the factors associated with its presence were collected and analyzed. A binary logistic regression was performed to assess multivariate relationships. Results: PA patients had higher PTH levels compared to the EH group (64 ± 42 vs. 39 ± 13 pg/mL, p = 0.004). Significative differences in PTH levels were observed according to the grade of hypertension in PA patients. Both hyperparathyroidism and CVD were found at higher rates in patients with PA. Patients with CVD exhibited significantly higher PAC values than patients without it (41.4 ± 18 vs. 21.4 ± 12 ng/dL, p < 0.001). Patients with hyperparathyroidism had higher rates of CVD than patients without it (58 vs. 24%, p = 0.018). Patients with PA and hyperparathyroidism manifested a higher rate of CVD than patients without this combination. A logistic regression showed an independent association of PAC and hyperparathyroidism with the presence of CVD in the total cohort. Conclusions: Hyperparathyroidism is associated with a higher probability of CVD both in PA and EH. The presence of hyperparathyroidism in PA seems to exacerbate the risk of CVD, with higher PTH levels associated with higher grades of hypertension in this cohort.
Full article
(This article belongs to the Section Adrenal Disorders and Electrolyte Balance)
►▼
Show Figures

Figure 1
Open AccessObituary
Prof. Em. Dr. med. Alex Vermeulen (1927–2023)—A Giant in Endocrinology
by
Carl De Crée
Endocrines 2025, 6(1), 7; https://doi.org/10.3390/endocrines6010007 - 10 Feb 2025
Abstract
►▼
Show Figures
Alex Vermeulen (1927–2023) was a leading Belgian endocrinologist whose name will forever remain linked to testosterone and androgen metabolism. As a dedicated scientist and clinician, he made seminal contributions to endocrinology throughout his career. These included the development of chromatography and radioimmunoassays of
[...] Read more.
Alex Vermeulen (1927–2023) was a leading Belgian endocrinologist whose name will forever remain linked to testosterone and androgen metabolism. As a dedicated scientist and clinician, he made seminal contributions to endocrinology throughout his career. These included the development of chromatography and radioimmunoassays of steroid hormones. His work also focused on the biological significance and metabolism of corticosteroids and androgens, and he defined key concepts in the role of steroid hormones in the human menstrual cycle, pregnancy, and menopause. His love for math, endocrinology, and problem-solving led to a formula for the estimation of free testosterone in serum, which has not been improved upon to date and is still in use worldwide. He contributed to enhancing our understanding of the role that male sex hormones may play in a variety of clinical problems in endocrinology, including bone health, type 2 diabetes, and, especially, endocrine function in aging males. Alex Vermeulen literally was “a giant in endocrinology”. Beyond his scientific contributions, Vermeulen was a wise and engaging mentor, a Renaissance man, and an aficionado of the finer things in life. He owned an eclectic choice of modern artworks, all of which he bequeathed to the Ghent Museum of Fine Arts, thus significantly enhancing the museum’s art patrimony.
Full article

Figure 1
Open AccessReview
Lifestyle Behaviors and Gestational Diabetes Mellitus: A Narrative Review
by
Eleftheria Taousani, Konstantinos-Georgios Papaioannou, Gesthimani Mintziori, Maria G. Grammatikopoulou, Angeliki Antonakou, Maria Tzitiridou-Chatzopoulou, Stavroula Veneti and Dimitrios G. Goulis
Endocrines 2025, 6(1), 6; https://doi.org/10.3390/endocrines6010006 - 10 Feb 2025
Abstract
Gestational diabetes mellitus (GDM) is a prevalent condition impacting approximately 14% of pregnancies globally, posing significant health risks to mother and child. This review explores the role of diet, physical activity (PA), and sedentary behavior (SB) in preventing and managing GDM. Consumption of
[...] Read more.
Gestational diabetes mellitus (GDM) is a prevalent condition impacting approximately 14% of pregnancies globally, posing significant health risks to mother and child. This review explores the role of diet, physical activity (PA), and sedentary behavior (SB) in preventing and managing GDM. Consumption of fish, fruits, vegetables, and legumes, and adherence to healthy dietary patterns, like the Mediterranean diet, are linked to lower GDM risk. Higher levels of PA and structured exercise consistently show protective effects against GDM, enhancing glucose metabolism and insulin sensitivity. Conversely, SB is a risk factor for GDM; prolonged sedentary periods detrimentally affect glucose regulation. The review emphasizes the need for a combined approach integrating healthy dietary habits, regular PA, and reduced SB to mitigate GDM risk effectively. Future research should prioritize standardized assessment methods and personalized lifestyle interventions to optimize GDM prevention strategies, ultimately informing public health guidelines and clinical recommendations for healthier pregnancies and better long-term outcomes.
Full article
(This article belongs to the Special Issue Advances in Diabetes Care)
►▼
Show Figures

Figure 1
Open AccessPerspective
Endocrine Parameters and Climate Change
by
Borros Arneth
Endocrines 2025, 6(1), 5; https://doi.org/10.3390/endocrines6010005 - 7 Feb 2025
Abstract
►▼
Show Figures
The endocrine system relies on complex cell signaling and epigenetic processes to adjust to the body’s needs. However, stressors such as climate change and heat can disrupt the endocrine system. This study aims to collect and systematically review evidence from publications exploring how
[...] Read more.
The endocrine system relies on complex cell signaling and epigenetic processes to adjust to the body’s needs. However, stressors such as climate change and heat can disrupt the endocrine system. This study aims to collect and systematically review evidence from publications exploring how climate change impacts endocrine laboratory parameters. The review process included developing research questions, defining inclusion and exclusion criteria, conducting database searches, screening and selecting relevant publications, collecting and analyzing data, interpreting the findings, and drawing conclusions. This review identified multiple endocrine parameters linked to climate change and the mechanisms by which various stressors disrupt endocrine function. Climate change, especially heat stress, affects the production and levels of key hormones. The mechanisms underlying the disruption of key hormones are also explored in this paper. This review provides a clear overview of how climate change influences endocrine parameters and outlines the processes underlying stress-triggered endocrine disruption.
Full article

Figure 1
Open AccessReview
Lipocalin 2 in Obesity and Diabetes: Insights into Its Role in Energy Metabolism
by
Erik Lindstrom, Jessica Deis, David A. Bernlohr and Xiaoli Chen
Endocrines 2025, 6(1), 4; https://doi.org/10.3390/endocrines6010004 - 14 Jan 2025
Abstract
Background: Lipocalin 2 (LCN2), also known as neutrophil gelatinase-associated lipocalin, is a 25 kDa protein involved in immune defense, inflammation, and metabolism. Results: LCN2 is widely expressed across various tissues, including immune cells, bone, adipose tissue, liver, kidneys, lung, spleen, and epithelial cells,
[...] Read more.
Background: Lipocalin 2 (LCN2), also known as neutrophil gelatinase-associated lipocalin, is a 25 kDa protein involved in immune defense, inflammation, and metabolism. Results: LCN2 is widely expressed across various tissues, including immune cells, bone, adipose tissue, liver, kidneys, lung, spleen, and epithelial cells, and exhibits sex- and fat depot-specific expression patterns. Structurally, LCN2 contains a hydrophobic lipid-binding pocket and glycosylation sites, enabling it to interact with diverse ligands and form dimers. In innate immunity, LCN2 plays a critical role by sequestering iron-laden siderophores, thereby restricting bacterial growth. Beyond its role in infection control, LCN2 is implicated in metabolic inflammation and diseases such as obesity and diabetes. Recent research has highlighted a pivotal role for LCN2 in mitochondrial phospholipid metabolism and mitochondrial function. In metabolic diseases and mitochondrial metabolism, LCN2 appears to display paradoxical effects. While some studies link it to improved insulin sensitivity, glucose regulation, and mitochondrial function, others associate it with insulin resistance, obesity, and mitochondrial dysfunction. These inconsistencies may arise from differences in experimental conditions and study populations. Conclusions: This review provides an up-to-date summary of LCN2’s multifaceted roles in obesity, diabetes, energy balance, and mitochondrial function, emphasizing its context-dependent effects. LCN2 appears to have dual roles, exerting both protective and detrimental outcomes depending on the physiological or pathological context, sex, cell types, and experimental conditions. Further research is necessary to unravel its complex functions and resolve conflicting findings, particularly in metabolic disorders.
Full article
(This article belongs to the Section Obesity, Diabetes Mellitus and Metabolic Syndrome)
►▼
Show Figures

Figure 1
Open AccessReview
Cinnamon Improves Glycated Haemoglobin and Body Mass Index, but Not Inflammatory Parameters in Patients with Type 2 Diabetes: Evidence from a Systematic Review and Meta-Analysis of Randomised Controlled Trials
by
Omorogieva Ojo, Gloria Aderonke Otunola, Omotayo Rebecca Oshungade and Beverly Joshua
Endocrines 2025, 6(1), 3; https://doi.org/10.3390/endocrines6010003 - 9 Jan 2025
Abstract
Background: Type 2 Diabetes (T2D) is increasingly becoming a critical healthcare priority globally. Medical interventions are primary strategies for managing diabetes, but more recently, diet/nutrition therapy, including the use of functional food products such as cinnamon and/or cinnamon products, has garnered considerable attention.
[...] Read more.
Background: Type 2 Diabetes (T2D) is increasingly becoming a critical healthcare priority globally. Medical interventions are primary strategies for managing diabetes, but more recently, diet/nutrition therapy, including the use of functional food products such as cinnamon and/or cinnamon products, has garnered considerable attention. The focus of this systematic review and meta-analysis is to examine whether cinnamon improves blood glucose parameters, body mass index, and inflammatory markers in people with T2DM. Method: PRISMA and PICOS frameworks were used for the review. EBSCOhost was used to search for relevant literature in health science research databases, while EMBASE and reference lists were used to access other relevant articles. Results: For systematic review and meta-analysis, 14 and 12 studies, respectively, were included (five from Iran, two each from the USA and India, and one each from the UK, China, Germany, Portugal, and Iraq). All participants had T2DM with ages ranging from ≥30–65 years. The effect of cinnamon on glycaemic control and other parameters did not follow a regular pattern. Effect on HbA1c (nine studies and 605 participants; MD of −0.07 (95% CI, −0.13, −0.01, p = 0.02), postprandial blood glucose (PBG) and BMI showed significant (p < 0.05) reductions. However, cinnamon exhibited no significant (p > 0.05) impact on FBG (MD of −1.73 (95% CI, −3.98, 0.52, p = 0.13), CRP, TNF-α, and IL-6 in people with T2D; neither did the sensitivity test reveal any change in relation to these parameters. Conclusions: Cinnamon or cinnamon extracts/products are significantly effective in diabetes management through reduction in HbA1c, PBG, and BMI.
Full article
(This article belongs to the Section Obesity, Diabetes Mellitus and Metabolic Syndrome)
►▼
Show Figures

Figure 1
Open AccessCase Report
Romosozumab as Treatment for Severe Osteoporosis in Heart and Lung Transplant Recipients
by
Lisa M. Raven, Jacqueline R. Center and Christopher A. Muir
Endocrines 2025, 6(1), 2; https://doi.org/10.3390/endocrines6010002 - 2 Jan 2025
Abstract
Background: Osteoporosis is common in transplant recipients, and fracture risk is high. Standard treatment is with anti-resorptive medications. Despite high fracture rates, there are limited data on the use of anabolic bone therapies in transplant recipients. Aim: To evaluate skeletal outcomes after treatment
[...] Read more.
Background: Osteoporosis is common in transplant recipients, and fracture risk is high. Standard treatment is with anti-resorptive medications. Despite high fracture rates, there are limited data on the use of anabolic bone therapies in transplant recipients. Aim: To evaluate skeletal outcomes after treatment with romosozumab for 12 months in heart and lung transplant recipients. Methods: Retrospective analysis of transplant recipients who completed 12 months of romosozumab treatment at a single centre. Results: Six transplant recipients completed 12 months of romosozumab treatment, commenced after a median of 3 years post transplant (range 2–20). Four patients (66%) were still receiving prednisolone treatment at the time of starting romosozumab. All patients had a history of fracture and had previously received anti-resorptive therapy (4 with zoledronate, 2 with denosumab for >2 years). Following completion of romosozumab treatment, all patients were consolidated with zoledronate or denosumab. Bone mineral density (BMD) was measured prior to and after completion of romosozumab treatment. The median baseline lumbar spine (LS) T-score was −2.3 SD (range −3.1 to +0.9) and total femur T-score was −2.2 SD (range −2.9 to −1.6). Most (5/6) patients experienced an increase in BMD at the LS (median change +7.1%). Most (5/6) patients did not experience clinically significant change in total femur BMD, apart from one patient who experienced a 9% gain. Three patients (50%) experienced subsequent fractures during (1/3) or after completing (2/3) romosozumab treatment. Conclusions: These cases demonstrate severe osteoporosis in transplant recipients. Most patients in our case series had improvement in LS BMD following romosozumab treatment, yet new fractures still occurred during follow-up. The appropriate use of romosozumab in heart and lung transplant patients with osteoporosis requires further study.
Full article
(This article belongs to the Topic Bone as an Endocrine Organ)
►▼
Show Figures

Figure 1
Open AccessArticle
Investigating the Effects of Testosterone and Dihydrotestosterone on Atherogenesis in Normoglycemic and Hyperglycemic Mouse Models
by
Daniel Venegas-Pino, Brooke D’Mello, Mark De Leon and Geoff H. Werstuck
Endocrines 2025, 6(1), 1; https://doi.org/10.3390/endocrines6010001 - 1 Jan 2025
Abstract
Objective: The effect of testosterone on the development of cardiovascular disease (CVD) is of interest due to the higher risk of CVD in men. This study aims to examine the impact of testosterone depletion and supplementation on atherosclerosis progression in normoglycemic and hyperglycemic
[...] Read more.
Objective: The effect of testosterone on the development of cardiovascular disease (CVD) is of interest due to the higher risk of CVD in men. This study aims to examine the impact of testosterone depletion and supplementation on atherosclerosis progression in normoglycemic and hyperglycemic mouse models. Methods: Male apolipoprotein E-deficient (ApoE−/−) and hyperglycemic (insulin deficient) ApoE−/−Ins2+/Akita mice were fed a standard chow diet and were either castrated or subjected to sham operations at 5 weeks of age. At 8 and 16 weeks of age, subsets of these mice were implanted subcutaneously with a silastic tube containing either 40 µL of dihydrotestosterone (DHT, 25 mg/mL) or sesame oil as a vehicle control. Survival was monitored and all remaining mice were sacrificed at 24 weeks of age. Blood, heart, and aortic samples were collected for analysis. Metabolic parameters were evaluated, and atherosclerotic lesion volumes were measured at the aortic sinus and in en face whole aorta mounts. Results: Castration significantly promoted atherosclerosis in normoglycemic mice, with a 3.0-fold increase (p < 0.05) at the aortic sinus and a 3.5-fold increase (p < 0.05) in en face aortas. However, in hyperglycemic mice, castration attenuated atherosclerosis in en face aortas. Supplementation with exogenous DHT led to increased atherosclerosis in hyperglycemic mice and was associated with significant cardiac-related mortality in 21–24-week-old hyperglycemic mice. Conclusions: In this mouse model, while testosterone/DHT may offer cardioprotective benefits under normoglycemic conditions, it appears to exert substantial harmful effects, such as promoting atherosclerosis and increasing the risk of myocardial infarction, in hyperglycemic conditions.
Full article
(This article belongs to the Section Lipid Metabolism and Cardiovascular Endocrinology)
►▼
Show Figures

Figure 1
Open AccessFeature PaperArticle
Testing for Endothelial Dysfunction in Children with Rare Genetic Variants of Obesity
by
Ilham Farhat and Vivian L. Chin
Endocrines 2024, 5(4), 613-620; https://doi.org/10.3390/endocrines5040044 - 10 Dec 2024
Abstract
Background: Endothelial dysfunction (ED), an early indicator of atherosclerosis, is a well-established predictor of cardiovascular disease. This study investigates ED in children with rare genetic variants linked to obesity and explores the prevalence of these variants in pediatric obesity. Methods: Under an IRB-approved
[...] Read more.
Background: Endothelial dysfunction (ED), an early indicator of atherosclerosis, is a well-established predictor of cardiovascular disease. This study investigates ED in children with rare genetic variants linked to obesity and explores the prevalence of these variants in pediatric obesity. Methods: Under an IRB-approved protocol, 54 pediatric patients with severe obesity (BMI ≥ 97%) were screened using the Rhythm® Genetics Test panel between 2021 and 2024 through the Uncovering Rare Obesity® program. This clinically approved buccal test targets 79 genes and one chromosomal region. ED was measured using EndoPAT® (Itamar Medical Ltd by Zoll US based company) in 24 of these patients with related gene variants and compared to controls. Results: Genetic screening: Among the 54 patients screened, 42 (78%) had positive genetic variants, including 18 males and 24 females. The most common variants were PCNT (n = 9), BBS (n = 9), SEMA3 (n = 8), ALMS1 (n = 6), SDCCAG8 (n = 5) and MC4R (n = 5). Endothelial dysfunction: Included 21 subjects with a mean age of 12 years and a mean BMI of 33.31 kg/m². The mean RHI for patients with the PCNT variant was significantly higher (1.34, p = 0.02) compared to controls, but no significant differences were observed for other variants, including BBS, ALMS1, and SH2B1. Conclusions: In this small pilot study, no significant difference in ED was found between children with or without genetic variants, except for PCNT, which showed a higher RHI. Targeted genetic screening revealed 78% with identified pathogenic variants like MC4R, which can clinically guide therapy. Further research is needed to investigate ED in children with obesity variants.
Full article
(This article belongs to the Section Obesity, Diabetes Mellitus and Metabolic Syndrome)
Highly Accessed Articles
Latest Books
E-Mail Alert
News
Topics
Topic in
Endocrines, IJMS, JCM, Women, Reprod. Med.
Gynecological Endocrinology Updates
Topic Editors: Alessandro Genazzani, Stefano LuisiDeadline: 30 November 2025
Topic in
Biomedicines, Diagnostics, Endocrines, JCM, JPM, IJMS
Development of Diagnosis and Treatment Modalities in Obstetrics and Gynecology
Topic Editors: Osamu Hiraike, Fuminori TaniguchiDeadline: 20 March 2026

Conferences
Special Issues
Special Issue in
Endocrines
Feature Papers in Endocrines 2025
Guest Editors: Antonio Brunetti, Maria MirabelliDeadline: 20 December 2025
Special Issue in
Endocrines
Recent Advances in Type 1 Diabetes
Guest Editors: Marina Basina, Daniela FotiDeadline: 31 March 2026